Suchergebnisse - "Anna Eramo"

PubPharm (8)

1

A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration

in: International Journal of Molecular Sciences | 2023

von Annarita Barone | Giuseppe De Simone | Mariateresa Ciccarelli | +5

2

Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

in: BMC Psychiatry | 2021

von Maggie McCue | Sara Sarkey | Anna Eramo | +2

3

The Effects of Antipsychotics on the Synaptic Plasticity Gene

in: International Journal of Molecular Sciences | 2020

von Felice Iasevoli | Elisabetta Filomena Buonaguro | Camilla Avagliano | +4

4

Adapting the Goal Attainment Approach for Major Depressive Disorder

in: Neurology and Therapy | 2019

von Maggie McCue | Sagar V. Parikh | Lisa Mucha | +6

5

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.

in: PLoS ONE | 2017

von Steven G Potkin | Jean-Yves Loze | Carlos Forray | +11

6

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

in: Drugs in Context | 2016

von Christophe Sapin | Ann Hartry | Siddhesh A Kamat | +3

7

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia

in: Drugs in Context | 2016

von Michele Wilson | Benjamin Gutierrez | Steve J Offord | +4

8

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients

in: Drugs in Context | 2015

von Siddhesh A Kamat | Steve Offord | John Docherty | +5

1
[1]